DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Zhang L, Li Y, Zhang S, Gao C, Nie K, Ji Y.
Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement: a case report.
Cancer Biol Med 2018;
15 (02) 178-181
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.